DE69505361D1 - Verfahren zur herstellung von kautabletten aus troxerutin, kalziumcarbonat kalziumphosphat, argininaspartat, argininglutamat, amoxicillin, eine kombination aus kalziumcarbonat und magnesiumcarbonat und eine kombination aus aluminiumhydroxyd und magnesiumhydroxyd - Google Patents

Verfahren zur herstellung von kautabletten aus troxerutin, kalziumcarbonat kalziumphosphat, argininaspartat, argininglutamat, amoxicillin, eine kombination aus kalziumcarbonat und magnesiumcarbonat und eine kombination aus aluminiumhydroxyd und magnesiumhydroxyd

Info

Publication number: DE69505361D1
Authority: DE; Germany
Prior art keywords: aluminum; carbonate; droxide; calcium; arginine
Prior art date: 1994-03-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69505361T

Other languages

English (en)

Other versions

DE69505361T2 (de

Inventor

Rosa Martani

Alain Gilles Demichelis

Nee Woiltock Maryvonne Barbero

Vu Dominique Le

Bertrand Lecointre

Patricia Rabot

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ethypharm SAS

Original Assignee

HI PHARMTECH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-17

Filing date

1995-03-17

Publication date

1998-11-19

1995-03-17 Application filed by HI PHARMTECH filed Critical HI PHARMTECH

1998-11-19 Publication of DE69505361D1 publication Critical patent/DE69505361D1/de

1999-06-17 Application granted granted Critical

1999-06-17 Publication of DE69505361T2 publication Critical patent/DE69505361T2/de

2015-03-18 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 title 4
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 title 2
229910052782 aluminium Inorganic materials 0.000 title 2
229910000019 calcium carbonate Inorganic materials 0.000 title 2
PPQREHKVAOVYBT-UHFFFAOYSA-H dialuminum;tricarbonate Chemical compound [Al+3].[Al+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O PPQREHKVAOVYBT-UHFFFAOYSA-H 0.000 title 2
SUUWYOYAXFUOLX-ZBRNBAAYSA-N (2s)-2-aminobutanedioic acid;(2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O.OC(=O)[C@@H](N)CCCN=C(N)N SUUWYOYAXFUOLX-ZBRNBAAYSA-N 0.000 title 1
RVEWUBJVAHOGKA-WOYAITHZSA-N Arginine glutamate Chemical compound OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CCCNC(N)=N RVEWUBJVAHOGKA-WOYAITHZSA-N 0.000 title 1
229940118662 aluminum carbonate Drugs 0.000 title 1
LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 title 1
229960002223 arginine aspartate Drugs 0.000 title 1
229960004246 arginine glutamate Drugs 0.000 title 1
108010013835 arginine glutamate Proteins 0.000 title 1
229960003563 calcium carbonate Drugs 0.000 title 1
239000001506 calcium phosphate Substances 0.000 title 1
229910000389 calcium phosphate Inorganic materials 0.000 title 1
229960001714 calcium phosphate Drugs 0.000 title 1
235000011010 calcium phosphates Nutrition 0.000 title 1
239000007910 chewable tablet Substances 0.000 title 1
ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 title 1
239000001095 magnesium carbonate Substances 0.000 title 1
229910000021 magnesium carbonate Inorganic materials 0.000 title 1
LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 title 1
IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 title 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 title 1
229960003232 troxerutin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Botany (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Confectionery (AREA)
Cosmetics (AREA)

DE69505361T 1994-03-17 1995-03-17 Verfahren zur herstellung von kautabletten aus troxerutin, kalziumcarbonat kalziumphosphat, argininaspartat, argininglutamat, amoxicillin, eine kombination aus kalziumcarbonat und magnesiumcarbonat und eine kombination aus aluminiumhydroxyd und magnesiumhydroxyd Expired - Lifetime DE69505361T2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9403142A FR2717387B1 (fr)	1994-03-17	1994-03-17	Procédé de fabrication de comprimés à croquer à base de troxérutine, de carbonate de calcium, de phosphate de calcium, d'aspartate d'arginine, de glutamate d'arginine d'amoxicilline.
PCT/FR1995/000332 WO1995024890A1 (fr)	1994-03-17	1995-03-17	Procede de fabrication de comprimes a croquer a base de troxerutine, de carbonate de calcium, de phosphate de calcium, d'aspartate d'arginine, de glutamate d'arginine, d'amoxicilline, de combinaison de carbonate de calcium et de carbonate de magnesium et de combinaison d'hydroxyde d'aluminium et d'hydroxyde de magnesium

Publications (2)

Publication Number	Publication Date
DE69505361D1 true DE69505361D1 (de)	1998-11-19
DE69505361T2 DE69505361T2 (de)	1999-06-17

Family

ID=9461155

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69505361T Expired - Lifetime DE69505361T2 (de)	1994-03-17	1995-03-17	Verfahren zur herstellung von kautabletten aus troxerutin, kalziumcarbonat kalziumphosphat, argininaspartat, argininglutamat, amoxicillin, eine kombination aus kalziumcarbonat und magnesiumcarbonat und eine kombination aus aluminiumhydroxyd und magnesiumhydroxyd

Country Status (8)

Country	Link
EP (1)	EP0750493B1 (de)
JP (1)	JP4018135B2 (de)
KR (1)	KR100364094B1 (de)
AU (1)	AU2076395A (de)
CA (1)	CA2185690A1 (de)
DE (1)	DE69505361T2 (de)
FR (1)	FR2717387B1 (de)
WO (1)	WO1995024890A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT407214B (de) *	1996-03-13	2001-01-25	Biochemie Gmbh	Verfahren zur herstellung von hilfsstoffefreien agglomeraten aus beta-lactamantibiotika
TWI225402B (en)	1996-03-13	2004-12-21	Biochemie Gmbh	Auxiliary-free agglomerates
SE0103211D0 (sv) *	2001-09-27	2001-09-27	Pharmacia Ab	New formulations and use thereof
US20030087937A1 (en) *	2001-10-15	2003-05-08	Nils-Olof Lindberg	Nicotine and cocoa powder compositions
SE0202365D0 (sv) *	2002-08-05	2002-08-05	Pharmacia Ab	New formulation and use thereof
SE0300831D0 (sv) *	2003-03-26	2003-03-26	Pharmacia Ab	New formulations and use therof
MXPA06013608A (es) *	2004-05-24	2007-04-26	Nycomed Pharma As	Particulado que comprende un compuesto que contiene calcio y un alcohol de azucar.
ATE430559T1 (de) *	2005-03-04	2009-05-15	Nycomed Pharma As	Verfahren zur herstellung von calciumzusammensetzungen im kontinuierlichen fliessbett
UA95093C2 (uk) *	2005-12-07	2011-07-11	Нікомед Фарма Ас	Спосіб одержання кальцієвмісної сполуки
FR2945748A1 (fr) *	2009-05-20	2010-11-26	Debregeas Et Associes Pharma	Medicament a base de calcium et de vitamine d.
WO2015020191A1 (ja) *	2013-08-09	2015-02-12	日東薬品工業株式会社	カルシウム剤
JP2015084771A (ja) *	2013-09-24	2015-05-07	アサヒ飲料株式会社	容器詰め果汁含有飲料、容器詰め果汁含有飲料の製造方法及び異風味抑制剤
EP3299010B1 (de) *	2016-09-21	2022-11-09	LTS Lohmann Therapie-Systeme AG	Orale darreichungsform
EP3758675A1 (de) *	2018-03-01	2021-01-06	LTS Lohmann Therapie-Systeme AG	Orale darreichungsform mit theobrominfreiem kakao
CN115969843B (zh) *	2023-03-17	2023-05-26	山东畜牧兽医职业学院	一种兽用抗感染的复方阿莫西林制剂及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4242323A (en) *	1979-08-22	1980-12-30	Vlock D G	Plaque inhibiting oral composition

1994
- 1994-03-17 FR FR9403142A patent/FR2717387B1/fr not_active Expired - Lifetime
1995
- 1995-03-17 AU AU20763/95A patent/AU2076395A/en not_active Abandoned
- 1995-03-17 DE DE69505361T patent/DE69505361T2/de not_active Expired - Lifetime
- 1995-03-17 JP JP52389095A patent/JP4018135B2/ja not_active Expired - Lifetime
- 1995-03-17 CA CA002185690A patent/CA2185690A1/fr not_active Abandoned
- 1995-03-17 EP EP95913216A patent/EP0750493B1/de not_active Expired - Lifetime
- 1995-03-17 KR KR1019960705150A patent/KR100364094B1/ko not_active Expired - Lifetime
- 1995-03-17 WO PCT/FR1995/000332 patent/WO1995024890A1/fr not_active Ceased

Also Published As

Publication number	Publication date
EP0750493A1 (de)	1997-01-02
KR100364094B1 (ko)	2003-03-04
FR2717387B1 (fr)	1996-10-18
KR970701533A (ko)	1997-04-12
AU2076395A (en)	1995-10-03
JP4018135B2 (ja)	2007-12-05
WO1995024890A1 (fr)	1995-09-21
DE69505361T2 (de)	1999-06-17
CA2185690A1 (fr)	1995-09-21
JPH09512788A (ja)	1997-12-22
EP0750493B1 (de)	1998-10-14
FR2717387A1 (fr)	1995-09-22
HK1012553A1 (en)	1999-08-06

Similar Documents

Publication	Publication Date	Title
DE69505361D1 (de)	1998-11-19	Verfahren zur herstellung von kautabletten aus troxerutin, kalziumcarbonat kalziumphosphat, argininaspartat, argininglutamat, amoxicillin, eine kombination aus kalziumcarbonat und magnesiumcarbonat und eine kombination aus aluminiumhydroxyd und magnesiumhydroxyd
DE19781601T1 (de)	1999-04-15	Flüssige orale anzuwendende Zusammensetzungen, die eine Calcium-Verbindung und ein Säuerungsmittel umfassen
DE69921881D1 (de)	2004-12-23	L-Glutaminsäure-herstellendes Bakterium und Verfahren zur Herstellung von L-Glutaminsäure
DE69941756D1 (de)	2010-01-21	L-Glutaminsäure herstellendes Bakterium und Verfahren zur Herstellung von Glutaminsäure
DE60033151D1 (de)	2007-03-15	L-aminosäure herstellendes bakterium und verfahren zur herstellung von l-aminosäure
ES2144077T3 (es)	2000-06-01	Formas de administracion que contienen sales solidas de acido r-tioctico con liberacion y biodisponibilidad mejoradas.
DE69419890D1 (de)	1999-09-09	Vorrichtung zur Herstellung selbststanzender Muttern
DE60120570D1 (de)	2006-07-27	Bakterium, das befähigt ist L-Glutaminsäure, L-Prolin und L-Arginin herzustellen, und Verfahren zur Herstellung von L-Glutaminsäure, L-Prolin und L-Arginin
DE69503385D1 (de)	1998-08-13	Kronenradgetriebe, kronenrad und verfahren und werkzeug zur herstellung des kronenrades
DE3587725D1 (de)	1994-02-24	Zahnpflegemittel, Vorrichtung und Verfahren zur Lagerung und Verabreichung desselben.
DE69429023D1 (de)	2001-12-13	Vorrichtung zur Herstellung von Stempeln
DE69535643D1 (de)	2007-12-27	Verfahren zur fermentativen Herstellung von L-Lysin und L-glutaminsäure
ATE245021T1 (de)	2003-08-15	Verfahren zur herstellung von flurbiprofen- lutschtabletten
DE69708818D1 (de)	2002-01-17	Verfahren zur Herstellung von Salpetersäure.
DE69800805D1 (de)	2001-06-21	Verfahren zur herstellung chiraler 3,4-epoxybuttersäure und ihrer salze
ATE400560T1 (de)	2008-07-15	Verfahren zur herstellung von 10,11 dihydro 10 hydroxy 5h-dibenz/b,f/azepin-5-carbonsäureamid und 10,11 dihydro 10 oxo-5h-dibenz/b,f/azepin-5 carbonsäureamid
HUP9800512A3 (en)	1998-12-28	Salts of bismuthum and antibiotica of the moenomycin group, process for producing them, their use and pharmaceutical compositions containing them
DE69113027D1 (de)	1995-10-19	Porige Calciumkarbonatteilchen und Verfahren zu ihrer Herstellung.
DK1047704T3 (da)	2003-06-23	Fremgangsmåde til fremstilling af lithium-, kalium-, calcium- og magnesiumsalte af fludarabin-phosphat og rensningsfremgangsmåde til fremstilling af fludarabin-phosphat og fludarabin-phosphat med en renhed på mindst 99,5%
DE3674623D1 (de)	1990-11-08	Tripeptide mit pharmazeutischer wirksamkeit und verfahren zu ihrer herstellung.
DE59608266D1 (de)	2002-01-03	Vorrichtung zur herstellung von tabletten
EE9800365A (et)	1999-04-15	Enantiomeerselt puhta asetidiin-2-karboksüülhappe saamise parandatud protsess
ATE237603T1 (de)	2003-05-15	Verbindungen und verfahren zur herstellung substituierter 4-phenyl-4-cyanocyclohexansäuren
ZA9710141B (en)	1998-06-25	Process for the preparation of salts and esters of clauvulanic acid.
TR28357A (tr)	1996-05-16	Karboksi-arensulfonik asitlerin ve bunlarin karbonik asit türevlerinin üretilmesine mahsus usul.

Legal Events

Date	Code	Title	Description
1999-04-08	8327	Change in the person/name/address of the patent owner	Owner name: LABORATOIRES PROGRAPHARM, CHATEAUNEUF-EN-THYMERAIS
1999-11-11	8364	No opposition during term of opposition
2003-12-24	8327	Change in the person/name/address of the patent owner	Owner name: ETHYPHARM S.A., HOUDAN, FR